1.
Belisari A, Iannazzo S, Di Pasquale G, Fresco C, Mantovani LG, Ruggeri MP, et al. [Budget impact analysis of idarucizumab for the management of patients treated with dabigatran in emergency / urgent situations in Italy]. FE [Internet]. 2016 Jun. 28 [cited 2025 Jul. 23];17(2):47-58. Available from: https://provafe.seedstm.com/index.php/FE/article/view/1243